Golumbeski George
- SEC CIK
- 0001586660
No open-market purchases or sales filed in the past year.
Current role at each company
- ABOS Acumen Pharmaceuticals, Inc.Directoras of Jun 5, 2026
- STTK Shattuck Labs, Inc.Directoras of Jun 2, 2026
- MURA Mural Oncology plcDirectoras of Dec 5, 2025
- SAGE Sage Therapeutics, Inc.Directoras of Jul 31, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Golumbeski George as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SAGE Sage Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 9, 2022 (view filing) | May 5 | 4 days | Golumbeski GeorgeDirector | PPurchase | +8.00K | $31.45 | +$251.6K | New position8.00K after |
STTK Shattuck Labs, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2022 (view filing) | Apr 26 | 1 day | Golumbeski GeorgeDirector | PPurchase | +28.3K | $3.63 | +$102.8K | +107.8%54.6K after | |
| Apr 26, 2022 (view filing) | Apr 21-22 | 5 daysLate | Golumbeski GeorgeDirector | PPurchase | +26.3K | $3.69 | +$97.0K | New position26.3K after | 2 lots |